nanolc-ms/ms - OmicsDI

Show results for

Proteomics (3637)
Unknown (330)
Metabolomics (10)
Other (5)
Genomics (2)
Transcriptomics (1)

Organisms

Homo sapiens (3486)
Mus musculus (3486)
Rattus norvegicus (3486)
Allexis (3485)
Arabidopsis thaliana (3485)
Entamoeba histolytica HM-1:IMSS-A (3485)
Escherichia coli (3485)
Listeria monocytogenes (3485)
Medicago truncatula (3485)
Meleagris gallopavo (3485)
Methylohalobius crimeensis 10Ki (3485)
Homo sapiens (39)
cellular organisms (28)
Mus musculus (17)
Aurantiacibacter marinus (1)
Bacillus infantis (1)
Bacillus pacificus (1)
Manihot esculenta (1)
Pseudomonas abyssi (1)
Rattus norvegicus (1)
Ruegeria sp. AD91A (1)
Vibrio azureus (1)
CL:0000066 (1)
Cryptococcus neoformans (1)
Mycobacterium tuberculosis variant bovis BCG (1)
Oryza sativa (1)
Sus scrofa (1)
Xenopus laevis (1)
Hordeum vulgare (1)
Triticum (1)

Organisms

Homo sapiens (1)

Repository

pride (3486)
jPOST (69)
MassIVE (55)
iProX (14)
MetaboLights (7)
PeptideAtlas (5)
GPMDB (4)
PanoramaPublic (4)
PAXDB (4)
GNPS (3)
ENA (2)
biostudies-arrayexpress (1)
NODE (1)

Tissue

Cell culture (662)
Epithelial cell (218)
Brain (205)
Liver (106)
Plant cell (96)
Blood plasma (92)
Colon (84)
Permanent cell line cell (79)
Leaf (76)
Kidney (74)
Fibroblast (59)
Heart (58)
Blood (56)
Lung (54)
Blood serum (53)
Cell suspension culture (49)
T cell (48)
HeLa cell (45)
Macrophage (44)
Blood cell (43)
Embryo (41)
Root (39)
Embryonic stem cell (38)
Skin (37)
Stem cell (35)
Saliva (31)
HCT-116 cell (30)
Hepatocyte (30)
Testis (30)
Plasma (1)

Disease

Breast cancer (81)
Colon cancer (76)
Disease free (71)
Acute leukemia (31)
Parkinson's disease (28)
Cervix carcinoma (26)
Melanoma (24)
Wounds and Injuries (23)
Alzheimer's disease (22)
Type 2 diabetes mellitus (19)
Brain cancer (16)
Cardiovascular system disease (15)
Lung cancer (15)
Lymphoma (15)
Malignant neoplasm of ovary (15)
Brain glioblastoma multiforme (14)
Obesity (12)
Glioblastoma (11)
Plasmodium falciparum malaria (11)
Prostate adenocarcinoma (11)
Cystic fibrosis (10)
Non-small cell lung carcinoma (10)
Prostate cancer (10)
Hepatocellular carcinoma (9)
Amyotrophic lateral sclerosis (8)
Chronic myeloid leukemia (7)
Infertility (7)
Influenza (7)
Multiple myeloma (7)
Not Available (4)

Technology Type

Mass Spectrometry (3486)
Shotgun proteomics (1958)
Bottom-up proteomics (539)
Affinity purification coupled with mass spectrometry proteomics (388)
Gel-based experiment (315)
Data-dependent acquisition (274)
SWATH MS (270)
Data-independent acquisition (120)
Top-down proteomics (120)
SRM/MRM (44)
Chemical cross-linking coupled with mass spectrometry proteomics (43)
Affinity proteomics (17)
All-ion fragmentation (15)
MSE (13)
DiaPASEF (10)
HDMSE (7)
Mass spectrometry (6)
Glycoproteomics (4)
Mass spectrometry imaging (4)
Metaproteomics (4)
Proteogenomics (4)
Gel-free quantification method (3)
Immunopeptidomics (2)
Mass spectrometry assay (1)
Gel-based quantification method (1)
RNA mass spectrometry (1)
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (1)

Instrument Platform

Q Exactive (12)
Orbitrap Eclipse (5)
Orbitrap Exploris 480 (5)
Orbitrap Fusion (5)
Orbitrap Fusion Lumos (5)
Instrument (4)
LTQ Orbitrap XL ETD (3)
MaXis II (3)
TripleTOF 5600 (2)
Impact II (2)
LTQ Orbitrap Elite (2)
LTQ Orbitrap XL (2)
6520A Quadrupole Time-of-Flight LC/MS (1)
6530A Q-TOF LC/MS (1)
Autoflex III TOF/TOF smartbeam (1)
Impact (1)
LTQ (1)
LTQ Orbitrap (1)
LTQ Orbitrap Velos (1)
MALDI Biotyper (1)
MaXis (1)
NanoLC-MS/MS (1)
Orbitrap Ascend (1)
Orbitrap Exploris 240 (1)
Orbitrap Fusion Lumos Tribrid Mass Spectrometer (1)
Q Exactive HF (1)
Q Exactive HF-X (1)
Q Exactive Plus (1)
QExactive (1)
QSTAR (1)

Publication Date

2022 (494)
2025 (454)
2021 (419)
2023 (410)
2024 (365)
2020 (289)
2019 (267)
2026 (266)
2018 (247)
2017 (145)
2016 (117)
2015 (86)
2014 (53)
2013 (13)
2005 (5)
2011 (2)
2008 (1)
2012 (1)
2010 (1)

UNIPROT ID/AC

A3FA66_VITVI (2)
A3FA68_VITVI (2)
A5ACP0_VITVI (2)
A5ACR7_VITVI (2)
A5AD40_VITVI (2)
A5ADC4_VITVI (2)
A5ADJ5_VITVI (2)
A5ADV7_VITVI (2)
A5AE63_VITVI (2)
A5AEB0_VITVI (2)
A5AEB4_VITVI (2)
A5AEB9_VITVI (2)
A5AEH1_VITVI (2)
A5AEI0_VITVI (2)
A5AEQ0_VITVI (2)
A5AEY1_VITVI (2)
A5AFH3_VITVI (2)
A5AFR3_VITVI (2)
A5AGD5_VITVI (2)
A5AGN5_VITVI (2)
A5AH05_VITVI (2)
A5AH21_VITVI (2)
A5AH72_VITVI (2)
A5AHJ5_VITVI (2)
A5AHP0_VITVI (2)
A5AHT6_VITVI (2)
A5AHY0_VITVI (2)
A5AI12_VITVI (2)
A5AIE0_VITVI (2)
A5AJ83_VITVI (2)

CHEBI ID

CHEBI:18272 (2)
CHEBI:27465 (2)
CHEBI:37713 (2)
CHEBI:17969 (2)
CHEBI:18199 (2)
CHEBI:16077 (2)
CHEBI:17052 (2)
CHEBI:17994 (2)
CHEBI:18319 (2)
CHEBI:18066 (2)
CHEBI:17013 (2)
CHEBI:15713 (2)
CHEBI:16264 (2)
CHEBI:17659 (2)
CHEBI:15721 (2)
CHEBI:48928 (2)
CHEBI:17050 (2)
CHEBI:16695 (2)
CHEBI:17533 (2)
CHEBI:52742 (2)
CHEBI:16227 (2)
CHEBI:78682 (2)
CHEBI:15351 (2)
CHEBI:14314 (2)
CHEBI:15996 (2)
CHEBI:17552 (2)
CHEBI:15422 (2)
CHEBI:16027 (2)
CHEBI:16761 (2)
CHEBI:17345 (2)

Metabolite Name

5'-phosphoribosyl-N-formylglycinamide (2)
5'-Thymidylic acid (2)
N-Acetyl-D-glucosamine 1,6-bisphosphate (2)
O-phospho-D-serine (2)
Shikimate-3-phosphate (2)
Sedoheptulose 1,7-bisphosphate (2)
Acetyl-CoA (2)
SAICAR (2)
5'-Guanylic acid (2)
Guanosine 5'-diphosphate (2)
UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-6-carboxy-L-lysyl-D-alanyl-D-alanine (2)
Uridine diphosphate glucose (2)
Ribose 1,5-bisphosphate (2)
Glucose-1-phosphate (2)
Uridine triphosphate (2)
Adenosine diphosphate (2)
Uridylic acid (2)
Adenosine 5'-monophosphate (2)
Sedoheptulose 7-phosphate (2)
Glucose-6 phosphate (2)
UDP-GlcNAc (2)
Adenosine triphosphate (2)
Guanosine triphosphate (2)
D-Fructose 1,6-bisphosphate (2)
N-Acetyl-L-glutamic acid (2)
Uridine 5'-diphosphate (2)
D-Ribose 5-phosphate (2)
6-phosphogluconic acid (2)
Uridine-5'-diphosphate-N-acetylmuramoyl-L-alanine (1)
Oxiglutatione (1)

First Public Date

2025 (1)
2014 (1)

Modification

Not available (13)
57.021464 (9)
15.994915 (8)
4-tetrahydrothiazine-3-carboxylic acid (8)
2x(15)N labeled L-lysine (6)
42.010565 (6)
4x(15)N labeled L-arginine (5)
N6-dimethyl-L-lysine (5)
-17.026549 (4)
-18.010565 (4)
0.984016 (3)
N6 (3)
+3amu) (2)
31.989829 (1)
4x(2)H labeled dimethylated L-lysine (1)
56.026215 (1)
6-dioxaoctanediamine derivatized cysteine (1)
79.966331 (1)

Study type

Transcription profiling by array (1)

Release Date

2020 (33)
2022 (29)
2015 (27)
2018 (26)
2021 (25)
2025 (23)
2023 (23)
2019 (23)
2016 (22)
2017 (20)
2024 (19)
2014 (17)
2013 (11)
2012 (10)
2011 (8)
2010 (6)
2008 (3)
2026 (3)
2009 (3)

Lab affiliation

EDyP (89)
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (46)
Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, Netherlands (40)
OncoProteomics Laboratory, Dept of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands (27)
Cornell University (13)
General and molecular microbiology, Institute for chemistry and biology of the marine environment (ICBM), Carl von Ossietzky University of Oldenburg, Oldenburg, Germany (13)
TIGEM (12)
USDA-ARS (11)
ETH Zurich (10)
Wageningen University (10)
CEA-Marcoule, ProGénoMIX platform, DRF-Li2D, 30207 Bagnols-sur-Cèze, France (9)
Imperial College London (9)
Vanderbilt University Proteomics Core (9)
Aarhus University, Denmark (8)
Instituto de Investigaciones Sanitarias de Santiago de Compostela (8)
Paris-Saclay Institute of Neuroscience, Team Melki, CNRS, Gif-sur-Yvette, France (8)
Center for Neuroscience and Cell Biology – University of Coimbra (7)
DIVAS, University of Milan (7)
Department of Convergence Medicine, Convergence Medicine Research Center/Biomedical Research Center, Asan Medical Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea. (7)
Head of Proteomics (7)
Head of the Curie Institute Mass Spectrometry Platform (7)
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences (7)
Mass Spectrometry/Proteomics Facility, Netherlands Cancer Institute, Amsterdam, Netherlands. (6)
Plateforme Oncoprot, TBM-Core US 005, F-33000 Bordeaux, France (6)
Bioplatforms Australia (5)
Center for Neuroscience and Cell Biology (5)
Core Facility Proteomics, Department of Clinical Chemistry, University Medical Center Goettingen, Germany (5)
Department of Life Science, National Taiwan University (5)
IGMM, CNRS, Univ Montpellier, Montpellier, France (5)
IGMM, CNRS, Université de Montpellier, Montpellier, France (5)

Tags

xref:PubMed:41347018 (1)

Previous page
1 / 399
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 399
Next page

Sort by:

Relevance

Page size

Online-2D nanoLC-MS for crude serum proteome profiling: assessing sample preparation impact on proteome composition

Although current LC-MS technology permits scientists to efficiently screen clinical samples in translational research, e.g. steroids, biogenic amines and even plasma or serum proteomes, in a daily routine, maintaining the balance between throughput and analytical depth is still a limiting factor. A ...

ORGANISM(S): Homo sapiens (Human)

2021-07-09 | PXD024893 | Pride

Bioinertization of NanoLC/MS/MS Systems by Depleting Metal Ions From the Mobile Phases for Phosphoproteomics.

Not available

S-EPMC10172917 | biostudies-literature

Deep Single-Shot NanoLC-MS Proteome Profiling with a 1500 Bar UHPLC System, Long Fully Porous Columns, and HRAM MS.

Not available

S-EPMC9552226 | biostudies-literature

Efficient Mapping of Sulfated Glycotopes by Negative Ion Mode nanoLC-MS/MS-Based Sulfoglycomic Analysis of Permethylated Glycans.

Not available

S-EPMC4843773 | biostudies-literature

Ultracentrifugation versus kit exosome isolation: nanoLC-MS and other tools reveal similar performance biomarkers, but also contaminations.

Not available

S-EPMC6331754 | biostudies-literature

Nanowell-mediated multidimensional separations combining nanoLC with SLIM IM-MS for rapid, high-peak-capacity proteomic analyses.

Not available

S-EPMC6500776 | biostudies-literature

Increasing proteome coverage with offline RP HPLC coupled to online RP nanoLC-MS.

Not available

S-EPMC3703961 | biostudies-literature

Discovery of PD-L1 Peptide Inhibitors from Ascidian Enzymatic Hydrolysates by Affinity Ultrafiltration Coupled to NanoLC-MS/MS.

Not available

S-EPMC12028738 | biostudies-literature

Bioinertization of nanoLC/MS/MS systems by depleting metal ions from the mobile phases for phosphoproteomics

We have successfully bioinertized a nanoLC/MS/MS system for the highly sensitive analysis of phosphopeptides by depleting metal ions from the mobile phase. We found that not only the direct contact of phosphopeptides with metal materials, but also the indirect contact with HPLC pump through the mobi...

ORGANISM(S): Homo Sapiens (human)

2023-03-24 | PXD034942 | JPOST Repository

A nanoLC-MS/MS system using a nonporous reverse phase column for ultrasensitive proteome analysis

The design of proteome projects is often restricted by the available amounts of sample, and thus there has been much effort to date to improve the sensitivity of proteome analyses. We have developed a new ultrasensitive nanoLC-MS system for the proteome analysis of microscale samples using a nonporo...

ORGANISM(S): Homo Sapiens (human)

2018-09-24 | PXD011168 | JPOST Repository

Previous page
1 / 399
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 399
Next page

Sort by:

Relevance

Page size

3985 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets